DS

Devender Singh Bakshi

Active Director Director DIN 08278541
DIN 08278541 First appointment Nov 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Devender Singh Bakshi

Data last updated:

Devender Singh Bakshi is a Director at Kapardi Pharma Private Limited (since 2018). The company operates in Chemicals.

DIN 08278541
Primary Designation Director
Industry Chemicals
First Appointment 13 Nov 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kapardi Pharma Private Limited U24100HR2018PTC076883
Director13 Nov 20182018Active

Board colleagues of Devender Singh Bakshi

Directorship timeline

Open interactive timeline →
Kapardi Pharma Private Limited
Premium access

Shareholding and investment profile for Devender Singh Bakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devender Singh Bakshi

Devender Singh Bakshi currently holds 1 directorship: Kapardi Pharma Private Limited (Director, since 13 Nov 2018).

Devender Singh Bakshi was first appointed on 13 Nov 2018 as Director at Kapardi Pharma Private Limited.

The current boards of Devender Singh Bakshi's companies include Anupama Bakshi (Kapardi Pharma Private Limited), Shubham Bakshi (Kapardi Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available